Insulet | PODD - 销售成本

金融业

USD

USD 2.99B

现金及等价物

USD 480.4M

USD 232.7M

USD 1.71B

USD 687.5M

USD 949.2M

USD 122M

USD 181.7M

3.9K

EPS每股收益

USD 1.42

股本和储备

USD 1.3B

USD 540.8M

债务利息支出

USD 14.7M

USD 5.7M

USD 929.5M

USD 11.07B

USD 91.1M

USD 639.7M

USD 122M

普通股股本

USD 69.26M

38.83

USD 113M

USD 761.7M

销售和管理费用

USD 317.2M

USD 462.5M

贸易债权人

USD 149.8M

应收帐款人

USD 544.7M

	销售成本	更改		日
Abbott	USD 5.94B		642M	2026-06
Align Technology	USD 303.5M		60.47M	2026-03
AtriCure	USD 34.98M		3.04M	2026-06
Avanos Medical	USD 88M		6.9M	2026-03
Baxter International	USD 1.81B		587M	2026-03
Becton, Dickinson and Co.	USD 2.56B		281M	2026-03
Boston Scientific	USD 1.83B		8M	2026-03
Cardinal Health	USD 58.54B		4.82B	2026-03
Cooper Companies	USD 393.8M		17M	2026-03
Dexcom	USD 441.6M		25.3M	2026-03
Edwards Lifesciences	USD 392.4M		29.8M	2026-06
Eli Lilly	USD 3.58B		205M	2026-03
Globus Medical	USD 263.59M		26.88M	2026-03
ICU Medical	USD 337.72M		1.61M	2025-12
Inogen	USD 39.59M		1.27M	2024-09
Insulet	USD 232.7M		17.5M	2026-03
Integra LifeSciences	USD 178.71M		14.73M	2026-03
J&J	USD 8B		67M	2026-06
Medtronic	USD 3.8B		195M	2026-03
Merit Medical Systems	USD 197.08M		1.5M	2026-03
Roche Holding	CHF 7.85B		630M	2026-06
Solventum Corp	USD 911M		60M	2026-03
Stryker	USD 2.36B		325M	2026-03
Tandem Diabetes Care	USD 122.92M		7.96M	2025-12
Teleflex	USD 240.84M		20.7M	2026-03
West Pharmaceutical Services	USD 543.1M		5.4M	2026-06
Zimmer Biomet Holdings	USD 738.3M		231.8M	2026-03